Inventor · disambiguated record
Stefan Seeber
Also filed as: SEEBER STEFAN
56 granted patents·45 pending applications·565 citations·filing 1991–2025
99Inventor score
Top patents by PatentIndex Score
101 records- 0197US8268314B2Bispecific anti-VEGF/anti-ANG-2 antibodiesBAEHNER MONIKA·Filed 2009·Granted Sep 18, 2012·70 cites·18 claims
- 0297US7501496B1Anti-OX40L antibodiesROCHE PALO ALTO LLC·Filed 2005·Granted Mar 10, 2009·87 cites·26 claims
- 0395US9499625B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2015·Granted Nov 22, 2016·12 cites·33 claims
- 0494US9879085B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2017·Granted Jan 30, 2018·10 cites·20 claims
- 0594US9663580B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2016·Granted May 30, 2017·11 cites·20 claims
- 0694US9499626B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2015·Granted Nov 22, 2016·12 cites·31 claims
- 0794US8703130B2Bispecific anti-VEGF/anti-ANG-2 antibodiesBAEHNER MONIKA·Filed 2012·Granted Apr 22, 2014·23 cites·12 claims
- 0893US11285207B2Bispecific antibodies specifically binding to PD1 and LAG3HOFFMANN LA ROCHE·Filed 2018·Granted Mar 29, 2022·10 cites·32 claims
- 0993US10011644B2Method for producing soluble FcR as Fc-fusion with inert immunoglobulin Fc-region and uses thereofHOFFMANN LA ROCHE·Filed 2015·Granted Jul 3, 2018·9 cites·3 claims
- 1093US9624302B2Nucleic acids encoding antibodies against human CSF-1RHOFFMANN LA ROCHE·Filed 2015·Granted Apr 18, 2017·11 cites·11 claims
- 1193US9617342B2Nucleic acids encoding antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2015·Granted Apr 11, 2017·11 cites·9 claims
- 1293US9499624B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2014·Granted Nov 22, 2016·12 cites·15 claims
- 1393US7868141B2Anti-OX40L antibodiesROCHE PALO ALTO LLC·Filed 2008·Granted Jan 11, 2011·21 cites·23 claims
- 1492US10718762B2Cellular based fret assay for the determination of simultaneous bindingHOFFMANN LA ROCHE·Filed 2018·Granted Jul 21, 2020·5 cites·8 claims
- 1592US9708396B2Bispecific anti-VEGF/anti-ANG-2 antibodiesHOFFMANN LA ROCHE·Filed 2014·Granted Jul 18, 2017·16 cites·17 claims
- 1692US9221910B2Antibodies against human CSF-1RFERTIG GEORG·Filed 2011·Granted Dec 29, 2015·20 cites·12 claims
- 1791US12023368B2ImmunoconjugatesHOFFMANN LA ROCHE·Filed 2022·Granted Jul 2, 2024·1 cites·20 claims
- 1891US10077314B1Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2018·Granted Sep 18, 2018·5 cites·20 claims
- 1991US10072087B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2017·Granted Sep 11, 2018·5 cites·20 claims
- 2091US9169323B2Antibodies against human CSF-1RFERTIG GEORG·Filed 2011·Granted Oct 27, 2015·13 cites·15 claims
- 2190US11214622B2Antibodies specific for DR5 and methods of useROCHE GLYCART AG·Filed 2018·Granted Jan 4, 2022·6 cites·13 claims
- 2290US10287352B2Bispecific antibodies specific for PD1 and TIM3HOFFMANN LA ROCHE·Filed 2016·Granted May 14, 2019·10 cites·21 claims
- 2390US9988458B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2016·Granted Jun 5, 2018·6 cites·14 claims
- 2490US9926379B2Bispecific antibodies specific for FAP and DR5, antibodies specific for DR5ROCHE GLYCART AG·Filed 2014·Granted Mar 27, 2018·17 cites·28 claims
- 2590US9102733B2Anti-OX40L antibodiesENDL JOSEPH·Filed 2010·Granted Aug 11, 2015·20 cites·17 claims
- 2690US7807158B2Antibodies against IL-13 receptor alpha1 and uses thereofROCHE PALO ALTO LLC·Filed 2006·Granted Oct 5, 2010·19 cites·9 claims
- 2790US7318918B2Interferon-alpha polypeptides and conjugatesMAXYGEN INC·Filed 2005·Granted Jan 15, 2008·11 cites·40 claims
- 2889US11130810B2Bispecific antibodies specific for PD1 and TIM3HOFFMANN LA ROCHE·Filed 2019·Granted Sep 28, 2021·4 cites·36 claims
- 2989US10030073B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2016·Granted Jul 24, 2018·5 cites·23 claims
- 3089US8999327B2Antibodies against human CSF-1R and uses thereofDIMOUDIS NIKOLAOS·Filed 2010·Granted Apr 7, 2015·16 cites·10 claims
- 3188US11413331B2ImmunoconjugatesHOFFMANN LA ROCHE·Filed 2018·Granted Aug 16, 2022·4 cites·30 claims
- 3288US10287358B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2018·Granted May 14, 2019·3 cites·20 claims
- 3386US9309319B2Antibodies against human IL33R and uses thereofHOFFMANN LA ROCHE·Filed 2014·Granted Apr 12, 2016·8 cites·7 claims
- 3484US10336830B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2018·Granted Jul 2, 2019·3 cites·15 claims
- 3584US2023399391A1Bispecific anti-vegf/anti-ang-2 antibodiesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 3684US2024270844A1Anti-tim3 antibodies and methods of useHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 3783US10023643B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2012·Granted Jul 17, 2018·5 cites·7 claims
- 3883US8883975B2Antibodies against IL-18R1 and uses thereofBRANDT MICHAEL·Filed 2011·Granted Nov 11, 2014·14 cites·22 claims
- 3983US2024294642A1Anti-pd1 antibodies and methods of useHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 4082US10570188B2Method for producing monomeric and multimeric molecules and uses thereofHOFFMANN LA ROCHE·Filed 2017·Granted Feb 25, 2020·3 cites·3 claims
- 4181US2023183349A1Anti-pd1 antibodies and methods of useHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 4280US2023279109A1Anti-tim3 antibodies and methods of useHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 4379US6573100B1DNA vectors without a selection marker geneROCHE DIAGNOSTICS GMBH·Filed 2001·Granted Jun 3, 2003·11 cites·8 claims
- 4478US2023143310A1Anti-pd1 antibodies and methods of useHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 4578US2025313629A1Anti-lag3 antibodiesHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 4676US7541163B2Interferon-alpha polypeptides and conjugatesMAXYGEN INC·Filed 2007·Granted Jun 2, 2009·1 cites·25 claims
- 4776US7531630B2Interferon-alpha polypeptides and conjugatesMAXYGEN INC·Filed 2006·Granted May 12, 2009·1 cites·27 claims
- 4876US2024002506A1Anti-lag3 antibodiesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 4976US2022363755A1Anti-tim3 antibodies and methods of useHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 5076US2025073308A1ImmunoconjugatesHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
Showing the top 50 of 101 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Stefan Seeber files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →